Association between myeloperoxidase levels and risk of coronary artery disease

JAMA

Volumn 286, Issue 17, 2001, Pages 2136-2142

  Zhang, R ^a   Brennan, M L ^a   Fu, X ^a   Aviles, R J ^a   Pearce, G L ^a   Penn, M S ^a   Topol, E J ^a   Sprecher, D L ^a   Hazen, S L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; ENZYME ANALYSIS; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0035824162     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.17.2136     Document Type: Article

References (50)

1. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
2. Leukocytes and the risk of ischemic disease
3. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease
4. Novel risk factors for atherosclerosis
5. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary artery disease: Meta-analyses of prospective studies
6. Myeloperoxidase deficiency - Phagocytic defects, I: Abnormalities outside of the respiratory burst
7. Primary inherited defects in neutrophil function: Etiology and treatment
8. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall
9. Myeloperoxidase-generated oxidants and atherosclerosis
10. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
11. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima
12. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions
13. p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima
14. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
15. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
16. Nitric oxide is a physiological substrate for mammalian peroxidases
17. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: A chloridedependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase
18. Antimicrobial activity of myeloperoxidase
19. Oxidation of guaiacol by myeloperoxidase: A two-electron -oxidized guaiacoltransient species as a mediator of NADPH oxidation
20. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
21. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death
22. Macrophage myeloperoxidase regulation by granulocyte macrophage colonystimulating, factor in human atherosclerosis and implications in acute coronary syndromes
23. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages
24. Immunologic detection and measurement of hypochlorite-modified LDL with specific monodonal antibodies
25. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein
26. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum
27. Formation of nitric oxidederived inflammatory oxidants by myeloperoxidase in neutrophils
28. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo
29. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins
30. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
31. Mass spectrometric quantification of markers for protein oxidation bytyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaque
32. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
33. The oxidative modification hypothesis of atherogenesis: An overview
34. Myeloperoxidase binds to low density lipoprotein: Potential implications for atherosclerosis
35. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro
36. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
37. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia
38. Studies on the chlorinating activity of myeloperoxidase
39. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils
40. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs
41. Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation
42. Nitric oxide modulates the catalytic activity of myeloperoxidase
43. Peroxidases inhibit nitric oxide (NO)-dependent bronchodilation: Development of a model describing NO-peroxidase interactions
44. Nitric oxide is a physiological substrate of plant and mammalian peroxidases
45. Consequences of total and subtotal myeloperoxidase deficiency: Risk or benefit?
46. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians
47. Increased atherosclerosis in myeloperoxidase-deficient mice
48. A discrete subpopulation of human monocytes expresses a neutrophil-like proinflammatory (P) phenotype
49. Characterization of human blood monocyte subset with low peroxidase activity
50. The oxidation of lipoproteins by monocytes-macrophages: Biochemical and biological mechanisms